Corticotropin-releasing hormone acts on CRH-R1 to inhibit the spontaneous contractility of non-labouring human myometrium at term

Life Sciences

Volumn 83, Issue 17-18, 2008, Pages 620-624

  Zhang, Lan Mei ^a   Wang, Yang Kai ^b   Hui, Ning ^a   Sha, Jin Yan ^a   Chen, Xiong ^a   Guan, Rui ^a   Dai, Ling ^a   Gao, Lu ^b   Yuan, Wen Jun ^b   Ni, Xin ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Contraction; Corticotropin releasing hormone; Myometrium; Parturition

Indexed keywords

ANTALARMIN; ASTRESSIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; FEMALE; HUMAN; HUMAN TISSUE; LABOR; MUSCLE CONTRACTILITY; MUSCLE CONTRACTION; MYOMETRIUM; PREGNANT WOMAN;

CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MYOMETRIUM; PREGNANCY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; UTERINE CONTRACTION;

EID: 53249105257     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.08.014     Document Type: Article

References (34)

1. Aggelidou E., Hillhouse E.W., and Grammatopoulos D.K. Up-regulation of nitric oxide synthase and modulation of the guanylate cyclase activity by corticotropin-releasing hormone but not urocortin II or urocortin III in cultured human pregnant myometrial cells. Proceedings of the National Academy of Sciences of the United States of America 99 5 (2002) 3300-3305
2. Benedetto C., Petraglia F., Marozio L., Chiarolini L., Florio P., Genazzani A.R., and Massobrio M. Corticotropin-releasing hormone increases prostaglandin F2 alpha activity on human myometrium in vitro. American Journal of Obstetrics and Gynecology 171 1 (1994) 126-131
3. Grammatopoulos D., Thompson S., and Hillhouse E.W. The human myometrium expresses multiple isoforms of the corticotropin-releasing hormone receptor. Journal of Clinical Endocrinology and Metabolism 80 8 (1995) 2388-2393
4. Grammatopoulos D.K., Dai Y., Randeva H.S., Levine M.A., Karteris E., Easton A.J., and Hillhouse E.W. A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes. Molecular Endocrinology 13 12 (1999) 2189-2202
5. Grammatopoulos D.K., Randeva H.S., Levine M.A., Katsanou E.S., and Hillhouse E.W. Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq-proteins. Molecular Endocrinology 14 12 (2000) 2076-2091
6. Hillhouse E.W., and Grammatopoulos D.K. Control of intracellular signalling by corticotropin-releasing hormone in human myometrium. Frontiers in Hormone Research 27 (2001) 66-74
7. Hillhouse E.W., and Grammatopoulos D.K. Role of stress peptides during human pregnancy and labour. Reproduction 124 3 (2002) 323-329
8. Hillhouse E.W., and Grammatopoulos D.K. The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. Endocrine Review 27 3 (2006) 260-286
9. Jin D., He P., You X., Zhu X., Dai L., He Q., Liu C., Hui N., Sha J., and Ni X. Expression of corticotropin-releasing hormone receptor type 1 and type 2 in human pregnant myometrium. Reproductive Science 14 6 (2007) 568-577
10. Karteris E., Goumenou A., Koumantakis E., Hillhouse E.W., and Grammatopoulos D.K. Reduced expression of corticotropin-releasing hormone receptor type-1 alpha in human preeclamptic and growth-restricted placentas. Journal of Clinical Endocrinology and Metabolism 88 1 (2003) 363-370
11. Karteris E., Hillhouse E.W., and Grammatopoulos D.K. Urocortin II is expressed in human pregnant myometrial cells and regulates myosin light chain phosphorylation: potential role of the type-2 corticotropin-releasing hormone receptor in the control of myometrial contractility. Endocrinology 145 2 (2004) 890-900
12. Korebrits C., Ramirez M.M., Watson L., Brinkman E., Bocking A.D., and Challis J.R. Maternal corticotropin-releasing hormone is increased with impending preterm birth. Journal of Clinical Endocrinology and Metabolism 83 5 (1998) 1585-1591
13. Kostich W.A., Chen A., Sperle K., and Largent B.L. Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor. Molecular Endocrinology 12 8 (1998) 1077-1085
14. Liaw C.W., Lovenberg T.W., Barry G., Oltersdorf T., Grigoriadis D.E., and de Souza E.B. Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid. Endocrinology 137 1 (1996) 72-77
15. Markovic D., Vatish M., Gu M., Slater D., Newton R., Lehnert H., and Grammatopoulos D.K. The onset of labor alters corticotropin-releasing hormone type 1 receptor variant expression in human myometrium: putative role of interleukin-1beta. Endocrinology 148 7 (2007) 3205-3213
16. Makrigiannakis A., Zoumakis E., Kalantaridou S., Coutifaris C., Margioris A.N., Coukos, Rice K.C., Gravanis A., and Chrousos G.P. Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance. Nature Immunology 2 11 (2001) 1018-1024
17. Makrigiannakis A., Semmler M., Briese V., Eckerle H., Minas V., Mylonas I., Friese K., and Jeschke U. Maternal serum corticotropin-releasing hormone and ACTH levels as predictive markers of premature labor. International Journal of Gynaecology and Obstetrics 97 2 (2007) 115-119
18. McLean M., Bisits A., Davies J., Woods R., Lowry P., and Smith R. A placental clock controlling the length of human pregnancy. Nature Medicine 1 5 (1995) 460-463
19. Mignot T.M., Paris B., Carbonne B., Vauge C., Ferre F., and Vaiman D. Corticotropin-releasing hormone effects on human pregnant vs. nonpregnant myometrium explants estimated from a mathematical model of uterine contraction. Journal of Applied Physiology 99 3 (2005) 1157-1163
20. Minas V., Jechke U., Kalantaridou S.N., Richter D.U., Mylonas I., Friese K., and Makrigiannakis A. Abortion is associated with increased expression of FasL in decidual leukocytes and apoptosis of extravillous trophoblasts: a role for CRH and urocortin. Molecular Human Reproduction 13 9 (2007) 663-673
21. Pisarchik A., and Slominski A.T. Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression. FASEB Journal 15 (2001) 2754-2756
22. Pisarchik A., and Slominski A. Molecular and functional characterization of novel CRFR1 isoforms from the skin. European Journal of Biochemistry 271 13 (2004) 2821-2830
23. Quartero H.W., and Fry C.H. Placental corticotrophin releasing factor may modulate human parturition. Placenta 10 5 (1989) 439-443
24. Riley S.C., and Challis J.R. Corticotrophin-releasing hormone production by the placenta and fetal membranes. Placenta 12 2 (1991) 105-119
25. Riley S.C., Walton J.C., Herlick J.M., and Challis J.R. The localization and distribution of corticotropin-releasing hormone in the human placenta and fetal membranes throughout gestation. Journal of Clinical Endocrinology and Metabolism 72 5 (1991) 1001-1007
26. Rodriguez-Linares B., Linton E.A., and Phaneuf S. Expression of corticotrophin-releasing hormone receptor mRNA and protein in the human myometrium. Journal of Endocrinology 156 1 (1998) 15-21
27. Sandman C.A., Glynn L., Schetter C.D., Wadhwa P., Garite T., Chicz-DeMet A., and Hobel C. Elevated maternal cortisol early in pregnancy predicts third trimester levels of placental corticotropin releasing hormone (CRH): priming the placental clock. Peptides 27 6 (2006) 1457-1463
28. Sasaki A., Shinkawa O., Margioris A.N., Liotta A.S., Sato S., Murakami O., Go M., Shimizu Y., Hanew K., and Yoshinaga K. Immunoreactive corticotropin-releasing hormone in human plasma during pregnancy, labor, and delivery. Journal of Clinical Endocrinology and Metabolism 64 2 (1987) 224-229
29. Simpkin J.C., Kermani F., Palmer A.M., Campa J.S., Tribe R.M., Linton E.A., and Poston L. Effects of corticotrophin releasing hormone on contractile activity of myometrium from pregnant women. British Journal of Obstetrics and Gynaecology 106 5 (1999) 439-445
30. Sirianni R., Mayhew B.A., Carr B.R., Parker Jr. C.R., and Rainey W.E. Corticotropin-releasing hormone (CRH) and urocortin act through type 1 CRH receptors to stimulate dehydroepiandrosterone sulfate production in human fetal adrenal cells. Journal of Clinical Endocrinology and Metabolism 90 (2005) 5393-5400
31. Valdenaire O., Giller T., Breu V., Gottowik J., and Kilpatrick G. A new functional isoform of the human CRF2 receptor for corticotropin-releasing factor. Biochimica et Biophysica Acta 1352 2 (1997) 129-132
32. Warren W.B., Patrick S.L., and Goland R.S. Elevated maternal plasma corticotropin-releasing hormone levels in pregnancies complicated by preterm labor. American Journal of Obstetrics and Gynecology 166 4 (1992) 1198-1204 discussion 1204-1197
33. Wetzka B., Sehringer B., Schafer W.R., Biller S., Hor C., Benedek E., Deppert W.R., and Zahradnik H.P. Expression patterns of CRH, CRH receptors, and CRH binding protein in human gestational tissue at term. Experimental and Clinical Endocrinology and Diabetes 111 3 (2003) 154-161
34. Wille S., Sydow S., Palchaudhuri M.R., Spiess J., and Dautzenberg F.M. Identification of amino acids in the N-terminal domain of corticotropin-releasing factor receptor 1 that are important determinants of high-affinity ligand binding. Journal of Neurochemistry 72 1 (1999) 388-395